KEY FEATURES
| Full Name | Fibroblast Growth Factor 23 |
|---|---|
| Synonym | FGF-23, ADHR, FGFN, HYPF, HPDR2, PHPTC |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 15.63-1000pg/mL |
| Sensitivity | 9.38pg/mL |
| Sample Type | Serum, plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse FGF23 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse FGF23. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse FGF23 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse FGF23, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse FGF23. You can calculate the concentration of Mouse FGF23 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse FGF23 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 45.6 | 87 | 476.58 | 43.74 | 82.98 | 512.15 |
| Standard deviation | 3.11 | 4.03 | 22.49 | 2.93 | 4.49 | 20.18 |
| CV(%) | 6.83 | 4.63 | 4.72 | 6.7 | 5.41 | 3.94 |
RECOVERY
The recovery of Mouse FGF23 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 87-99 | 93 |
| EDTA plasma (n=8) | 90-104 | 96 |
| Cell culture media (n=8) | 91-105 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse FGF23 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with Fgf23 ELISA Kits
| Fgfr1 ELISA Kit | publications with Fgf23 and Fgfr1 |
| Fgfr4 ELISA Kit | publications with Fgf23 and Fgfr4 |
| Fgfr3 ELISA Kit | publications with Fgf23 and Fgfr3 |
| Fgfr2 ELISA Kit | publications with Fgf23 and Fgfr2 |
| Fgf8 ELISA Kit | publications with Fgf23 and Fgf8 |
| Fgf9 ELISA Kit | publications with Fgf23 and Fgf9 |
| Fgf18 ELISA Kit | publications with Fgf23 and Fgf18 |
| Fgf20 ELISA Kit | publications with Fgf23 and Fgf20 |
| Fgf17 ELISA Kit | publications with Fgf23 and Fgf17 |
Pathways associated with Fgf23 ELISA Kit
| ARMS-mediated Activation Pathway | ARMS-mediated Activation Pathway |
| Adaptive Immune System Pathway | Adaptive Immune System Pathway |
| Axon Guidance Pathway | Axon Guidance Pathway |
| Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
| DAP12 Interactions Pathway | DAP12 Interactions Pathway |
| DAP12 Signaling Pathway | DAP12 Signaling Pathway |
| Developmental Biology Pathway | Developmental Biology Pathway |
| Downstream Signal Transduction Pathway | Downstream Signal Transduction Pathway |
| Downstream Signaling Events Of B Cell Receptor (BCR) Pathway | Downstream Signaling Events Of B Cell Receptor (BCR) Pathway |
| Downstream Signaling Of Activated FGFR1 Pathway | Downstream Signaling Of Activated FGFR1 Pathway |
Diseases associated with Fgf23 ELISA Kit
| Kidney Diseases | publications with Fgf23 and Kidney Diseases |
| Phosphorus Metabolism Disorders | publications with Fgf23 and Phosphorus Metabolism Disorders |
| Rickets | publications with Fgf23 and Rickets |
| Renal Insufficiency | publications with Fgf23 and Renal Insufficiency |
| Hyperphosphatemia | publications with Fgf23 and Hyperphosphatemia |
| Calcinosis | publications with Fgf23 and Calcinosis |
| Hypertension | publications with Fgf23 and Hypertension |
| Hypertrophy | publications with Fgf23 and Hypertrophy |
| Death | publications with Fgf23 and Death |
| Inflammation | publications with Fgf23 and Inflammation |
Organs/Tissues associated with Fgf23 ELISA Kit
| Blood | publications with Fgf23 and Blood |
| Skin | publications with Fgf23 and Skin |
| Spleen | publications with Fgf23 and Spleen |
| Pancreas | publications with Fgf23 and Pancreas |
| Inner Ear | publications with Fgf23 and Inner Ear |